Greenbaum B H
Department of Pediatrics, Cooper Hospital Medical Center, Camden, New Jersey 08103.
Am J Pediatr Hematol Oncol. 1990 Winter;12(4):490-6. doi: 10.1097/00043426-199024000-00015.
The use of intravenous gamma globulin products in both children and adults has increased markedly over the past 5 years, since these agents were licensed in the United States. Product competition has become fierce, with each supplier touting the merits of its own product. A summary of the six products currently available in the United States is presented. Comparisons are made according to method of product manufacture, product specifications, antibody titers, opsonization data, IgG subclass quantification, ease of administration, and side effects.
自静脉注射用丙种球蛋白产品在美国获得许可以来，过去5年里，儿童和成人对这类产品的使用显著增加。产品竞争变得激烈，每个供应商都在吹嘘自家产品的优点。本文列出了目前在美国可获得的六种产品的概述。并根据产品制造方法、产品规格、抗体效价、调理作用数据、IgG亚类定量、给药便利性和副作用进行了比较。
